
### [NCIT:C4436](http://purl.obolibrary.org/obo/NCIT_C4436)
**Label:** Cholangiocarcinoma

**Subclasses:** [NCIT:C134751](http://purl.obolibrary.org/obo/NCIT_C134751) (Stage IV Hilar Cholangiocarcinoma AJCC v8), [NCIT:C134756](http://purl.obolibrary.org/obo/NCIT_C134756) (Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C134514](http://purl.obolibrary.org/obo/NCIT_C134514) (Intrahepatic Cholangiocarcinoma by AJCC v7 Stage), [NCIT:C134755](http://purl.obolibrary.org/obo/NCIT_C134755) (Intrahepatic Cholangiocarcinoma by AJCC v8 Stage), [NCIT:C41619](http://purl.obolibrary.org/obo/NCIT_C41619) (Signet Ring Cell Intrahepatic Cholangiocarcinoma), [NCIT:C41618](http://purl.obolibrary.org/obo/NCIT_C41618) (Mucin-Producing Intrahepatic Cholangiocarcinoma), [NCIT:C41617](http://purl.obolibrary.org/obo/NCIT_C41617) (Cholangiolocellular Carcinoma), [NCIT:C128807](http://purl.obolibrary.org/obo/NCIT_C128807) (Recurrent Intrahepatic Cholangiocarcinoma), [NCIT:C43848](http://purl.obolibrary.org/obo/NCIT_C43848) (Clear Cell Intrahepatic Cholangiocarcinoma), [NCIT:C88049](http://purl.obolibrary.org/obo/NCIT_C88049) (Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7), [NCIT:C134757](http://purl.obolibrary.org/obo/NCIT_C134757) (Stage I Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C88060](http://purl.obolibrary.org/obo/NCIT_C88060) (Stage II Hilar Cholangiocarcinoma AJCC v7), [NCIT:C35417](http://purl.obolibrary.org/obo/NCIT_C35417) (Intrahepatic Cholangiocarcinoma), [NCIT:C134761](http://purl.obolibrary.org/obo/NCIT_C134761) (Stage III Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C134760](http://purl.obolibrary.org/obo/NCIT_C134760) (Stage II Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C134745](http://purl.obolibrary.org/obo/NCIT_C134745) (Stage I Hilar Cholangiocarcinoma AJCC v8), [NCIT:C134744](http://purl.obolibrary.org/obo/NCIT_C134744) (Stage 0 Hilar Cholangiocarcinoma AJCC v8), [NCIT:C134743](http://purl.obolibrary.org/obo/NCIT_C134743) (Hilar Cholangiocarcinoma by AJCC v8 Stage), [NCIT:C134742](http://purl.obolibrary.org/obo/NCIT_C134742) (Hilar Cholangiocarcinoma by AJCC v7 Stage), [NCIT:C134764](http://purl.obolibrary.org/obo/NCIT_C134764) (Stage IV Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C8265](http://purl.obolibrary.org/obo/NCIT_C8265) (Adult Cholangiocarcinoma), [NCIT:C27325](http://purl.obolibrary.org/obo/NCIT_C27325) (Recurrent Cholangiocarcinoma), [NCIT:C96949](http://purl.obolibrary.org/obo/NCIT_C96949) (Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma), [NCIT:C88058](http://purl.obolibrary.org/obo/NCIT_C88058) (Stage 0 Hilar Cholangiocarcinoma AJCC v7), [NCIT:C88059](http://purl.obolibrary.org/obo/NCIT_C88059) (Stage I Hilar Cholangiocarcinoma AJCC v7), [NCIT:C36077](http://purl.obolibrary.org/obo/NCIT_C36077) (Hilar Cholangiocarcinoma), [NCIT:C88050](http://purl.obolibrary.org/obo/NCIT_C88050) (Stage I Intrahepatic Cholangiocarcinoma AJCC v7), [NCIT:C88051](http://purl.obolibrary.org/obo/NCIT_C88051) (Stage II Intrahepatic Cholangiocarcinoma AJCC v7), [NCIT:C134747](http://purl.obolibrary.org/obo/NCIT_C134747) (Stage III Hilar Cholangiocarcinoma AJCC v8), [NCIT:C134746](http://purl.obolibrary.org/obo/NCIT_C134746) (Stage II Hilar Cholangiocarcinoma AJCC v8), [NCIT:C88052](http://purl.obolibrary.org/obo/NCIT_C88052) (Stage III Intrahepatic Cholangiocarcinoma AJCC v7), [NCIT:C96805](http://purl.obolibrary.org/obo/NCIT_C96805) (Peripheral Intrahepatic Cholangiocarcinoma), 

**Class expressions from DL-Learner:**

- [UBERON:0003704](http://purl.obolibrary.org/obo/UBERON_0003704) (intrahepatic bile duct) 57.50%
- Thing 53.64%
- [UBERON:0015423](http://purl.obolibrary.org/obo/UBERON_0015423) (hilar portion of hepatic duct) 52.50%
- [UBERON:0005171](http://purl.obolibrary.org/obo/UBERON_0005171) (hepatic duct) 52.50%
- [UBERON:0001282](http://purl.obolibrary.org/obo/UBERON_0001282) (intralobular bile duct) 52.50%
- [UBERON:0001246](http://purl.obolibrary.org/obo/UBERON_0001246) (interlobular bile duct) 52.50%
- [UBERON:0003704](http://purl.obolibrary.org/obo/UBERON_0003704) (intrahepatic bile duct) and [UBERON:0035050](http://purl.obolibrary.org/obo/UBERON_0035050) (excretory duct) 52.50%
- [UBERON:0003704](http://purl.obolibrary.org/obo/UBERON_0003704) (intrahepatic bile duct) and [UBERON:0014716](http://purl.obolibrary.org/obo/UBERON_0014716) (interlobular duct) 52.50%
- [UBERON:0002394](http://purl.obolibrary.org/obo/UBERON_0002394) (bile duct) and [UBERON:0035050](http://purl.obolibrary.org/obo/UBERON_0035050) (excretory duct) 52.50%
- [UBERON:0002394](http://purl.obolibrary.org/obo/UBERON_0002394) (bile duct) and [UBERON:0014716](http://purl.obolibrary.org/obo/UBERON_0014716) (interlobular duct) 52.50%
- [UBERON:0002394](http://purl.obolibrary.org/obo/UBERON_0002394) (bile duct) 41.62%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 32.00%
- [UBERON:0004119](http://purl.obolibrary.org/obo/UBERON_0004119) (endoderm-derived structure) 27.86%
- [UBERON:0000061](http://purl.obolibrary.org/obo/UBERON_0000061) (anatomical structure) 20.85%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 20.81%


